Loading company…
Trillium Therapeutics develops immuno-oncology therapies for cancer treatment.
Trillium Therapeutics develops cancer therapies that use the immune system. Founded in 2004 and based in Mississauga, Canada, the company had three funding rounds. In February 2012, it raised CAD 2 million from Covington and GrowthWorks Capital, with prior participation from BDC Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in